Cytek BioSciences 

$3.77
28
-$0.21-5.28% Thursday 20:00

Statistics

Day High
4.08
Day Low
3.7
52W High
6.18
52W Low
2.9
Volume
15,687,850
Avg. Volume
-
Mkt Cap
482.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.15
-0.06
0.03
0.12
Expected EPS
-0.085
Actual EPS
N/A

Financials

-3%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
400.91MRevenue
-12.04MNet Income

Analyst Ratings

5.08Average Price Target
The highest estimate is 5.50.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTKB. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biodesix
BDSX
Mkt Cap155.96M
Biodesix is a competitor because it also operates in the biotechnology sector focusing on diagnostic solutions, similar to Cytek's focus on cell analysis technologies.
Guardant Health
GH
Mkt Cap17.45B
Guardant Health operates in the precision oncology field, offering liquid biopsies and cancer diagnostics that compete with Cytek's diagnostic solutions.
Illumina
ILMN
Mkt Cap24.35B
Illumina, Inc. competes with Cytek through its next-generation sequencing (NGS) technologies, which are used in genetic analysis and overlap with Cytek's cell analysis market.
Pacific Biosciences of California
PACB
Mkt Cap406.89M
Pacific Biosciences of California offers long-read sequencing technologies, competing in the broader genomics and cell analysis market that Cytek targets.
Qiagen NV
QGEN
Mkt Cap7.64B
QIAGEN N.V. provides sample and assay technologies for molecular diagnostics, competing with Cytek in the life sciences and molecular diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap174.42B
Thermo Fisher Scientific offers a wide range of analytical instruments and reagents, including those for cell analysis, directly competing with Cytek's product offerings.
Danaher
DHR
Mkt Cap127.47B
Danaher Corporation, through its Life Sciences segment, offers products and services that compete with Cytek's cell analysis and cytometry solutions.
Agilon Health
AGL
Mkt Cap1.88B
Agilent Technologies provides instruments, services, and consumables for laboratories, including cell analysis technologies that compete with Cytek BioSciences.

About

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
Show more...
CEO
Dr. Wenbin Jiang Ph.D.
Employees
663
Country
United States
ISIN
US23285D1090

Listings

0 Comments

Share your thoughts

FAQ

What is Cytek BioSciences stock price today?
The current price of CTKB is $3.77 USD — it has decreased by -5.28% in the past 24 hours. Watch Cytek BioSciences stock price performance more closely on the chart.
What is Cytek BioSciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cytek BioSciences stocks are traded under the ticker CTKB.
Is Cytek BioSciences stock price growing?
CTKB stock has fallen by -4.8% compared to the previous week, the month change is a -4.8% fall, over the last year Cytek BioSciences has showed a +27.8% increase.
What is Cytek BioSciences market cap?
Today Cytek BioSciences has the market capitalization of 482.05M
When is the next Cytek BioSciences earnings date?
Cytek BioSciences is going to release the next earnings report on August 12, 2026.
What were Cytek BioSciences earnings last quarter?
CTKB earnings for the last quarter are -0.15 USD per share, whereas the estimation was -0.09 USD resulting in a -62.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cytek BioSciences revenue for the last year?
Cytek BioSciences revenue for the last year amounts to 400.91M USD.
What is Cytek BioSciences net income for the last year?
CTKB net income for the last year is -12.04M USD.
How many employees does Cytek BioSciences have?
As of June 21, 2026, the company has 663 employees.
In which sector is Cytek BioSciences located?
Cytek BioSciences operates in the Health & Wellness sector.
When did Cytek BioSciences complete a stock split?
Cytek BioSciences has not had any recent stock splits.
Where is Cytek BioSciences headquartered?
Cytek BioSciences is headquartered in Fremont, United States.